Keywords: zeneca, sees, strong, growth, against, odds, pharmaceuticals
Zeneca Sees Strong Growth Against The Odds
Article | 08 August 1997
Zeneca Pharmaceuticals has reported strong first-half 1997 results,ahead of expectations, with underlying sales and pretax profit rising by 10% and 22%, respectively. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
